A Multiple Ascending Dose Study of Pegozafermin in Participants With Biopsy Confirmed Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) and at High Risk of NASH
Clinical trial NCT04048135 · COMPLETED
Trial details
- NCT number
- NCT04048135
- Sponsor
- 89bio, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-29
- Primary completion
- 2020-08-28
- Enrollment
- 101
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.